Compositions and methods for culturing stem cells

• US 20060128014A1
• Filed: 08/26/2003
• Published: 06/15/2006
• Est. Priority Date: 08/26/2002
• Status: Abandoned Application

• Current Assignee: NeuroNova AB (Newron Pharmaceuticals Spa)
• Original Assignee: NeuroNova AB (Newron Pharmaceuticals Spa)
• Inventors: Jansson, Katarina, Ronnholm, Harriet, Haggblad, Johan, Horrocks, Carolyn
• Application Number:
  US10/525,930
• Publication Number:
  US 20060128014A1
• Time in Patent Office: Days
• US Class Current: 435/368
• CPC Class Codes: C12N 2500/20 Transition metals
• CPC Class Codes: C12N 2501/11 Epidermal growth factor [EGF]
• CPC Class Codes: C12N 2501/115 Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 2501/35 Vasoactive intestinal peptide [VIP]; Pituitary adenylate cyclase activating polypeptide [PACAP]
• CPC Class Codes: C12N 2501/70 Enzymes
• CPC Class Codes: C12N 5/0623 Stem cells

Abstract

The present invention provides methods of culturing, propagating, treating, and maintaining stem cells in the presence of a phosphate mimic. In particular, the invention relates to the propagation of stem cells in vitro, the formation of neurospheres in vitro, and to tissue culture of stem cells in the presence of a phosphate mimic. The invention further relates to the treatment of neurodegenerative disorders.

Claims

1. A method for culturing a stem cell, said method comprising propagating the stem cell in tissue culture medium comprising an agent selected from the group consisting of an inhibitor of a PTPase, a modulator of an enzyme with one or more phosphate binding sites, a phosphohydrolase, a pyrophosphatase, an alkaline phosphatase, an acid phosphatase, and a modulator of a protein with one or more pTyr recognition unit.

2. The method of claim 1, wherein the pTyr recognition unit is a SH2 domain.

3. The method of claim 1, wherein the enzyme with one or more phosphate binding sites is a glucose-6-phosphate dehydrogenase, a fructose-2,6-bisphosphatase, a phosphoglucomutase, a Mg²⁺ dependent ATPase, a plasma membrane Ca²⁺ ATPases, an endoplamic reticulum Ca²⁺-ATPases, a P-glycoprotein ATPase activity, a Mg²⁺-dependent vanadate-sensitive GS-conjugate export ATPase, a MRP/GS-X pump, and a Na⁺, K⁺-ATPase.

17. A cultured stem cell, wherein the cultured stem cell has been generated by the method of any one of claims 1, 4, 5, 10 or 14.

34. The method of any one of claims 1, 4, 5, 10, 14, 19, or 20, wherein the culture medium further comprises an agent selected from the group consisting of a growth factor, a Receptor Tyrosine Kinase agonist, and a growth factor secretagogue.

35. The method of any one of claims 1, 4, 5, 10, 14, 19, or 20, wherein the culture medium further comprises an agent selected from the group consisting of an agonist of cAMP accumulation, a Ca²⁺-transient triggering factor, and an agonist of cGMP accumulation.

4. A method for culturing a stem cell, said method comprising propagating the stem cell in tissue culture medium comprising a phosphate mimic.

5. A method for culturing a stem cell, said method comprising incubating the stem cells in tissue culture medium comprising a phosphate mimic.

6. The method of claim 5, wherein the tissue culture medium comprises between 1 μ

M and 10 μ

M vanadate, between 10 μ

M and 50 μ

M vanadate, between 50 μ

M and 100 μ

M vanadate, between 100 μ

M and 500 μ

M vanadate or between 500 μ

M and 1000 μ

M vanadate.

7. The method of claim 5, wherein the tissue culture medium comprises a phosphate mimic, and wherein the culture medium is not supplemented with exogenously added growth factor.

8. The method of claim 5, wherein the tissue culture medium comprises a phosphate mimic, and wherein the incubating step elevates intracellular ATP levels in the neural stem cell by at least 25% compared to intracellular ATP levels in the stem cell incubated without phosphate mimic under otherwise same conditions.

44. The method of claim 5, wherein the stem cell undergoes self-renewal.

9. (canceled)

10. A method for culturing a stem cell, said method comprising incubating the stem cell in tissue culture medium comprising a phosphate mimic, wherein the amount of phosphate mimic is sufficient for stem cells to exhibit at least 25% more proliferation than stem cells incubated without the phosphate mimic under otherwise same conditions.

30. The method of any one of claims 4, 5, 10, 14, 19, or 20, wherein the phosphate mimic is selected from the group consisting of a vanadium oxide, a derivative of a vanadium oxide, a polyoxometalate, a homopolyoxotungstate, a vanadium-substituted polyoxotungstate, an esterified derivative of 4-(fluoromethyl)phenyl phosphate, a homopolyoxoselenate, a vanadium-substituted polyoxoselenate, a homopolyoxomolybdate, a vanadium-substituted polyoxomolybdate, and a PTPase inhibitor.

31. The method of any one of claims 4, 5, 10, 14, 19, or 20, wherein the phosphate mimic is vanadate, orthovanadate, metavanadate, pervanadate, vanadate dimer, vanadate tetramer, vanadate pentamer, vanadate hexamer, vanadate heptamer, vanadate octamer, vanadate nonamer, vanadate decamer, vanadate polymer, vanadyl sulfate, bis(6, ethylpicolinato)(H(2)O)oxovanadium(IV) complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), bis(maltolato)oxovanadium (IV), bis(biguanidato)oxovanadium(IV), bis(N′

N′

-dimethylbiguanidato)oxovanadium(IV), bis(beta-phenethyl-biguanidato)oxovanadium(IV), peroxovanadate-nicotinic acid, aluminiofluoride, 4-(fluoromethyl)phenyl phosphate, tungstate, selenate, molybdate, Zn²⁺ or F<sup>−

1</sup>.

32. The method of any one of claims 31, wherein the phosphate mimic is vanadate.

33. The method of claim 32, wherein the concentration of vanadate in the culture medium is 1 μ

M, 10 μ

M, 50 μ

M, 100 μ

M, 500 μ

M or 1000 μ

M.

37. The method of claim 4, 5, 10, 14, 19, or 20, wherein the cell does not substantially differentiate during the incubating step.

11-13. -13. (canceled)

14. A method for culturing a neural stem cell, said method comprising incubating the neural stem cell in tissue culture medium comprising a phosphate mimic, wherein the incubating step increases formation of neurospheres from the neural stem cell by at least 25% compared to the formation of neurospheres from the stem cell incubated without phosphate mimic under otherwise same conditions.

15-16. -16. (canceled)

18. (canceled)

19. A method for culturing a progenitor cell, said method comprising propagating the progenitor cell in tissue culture medium comprising a phosphate mimic.

29. A cultured progenitor cell, wherein the cultured progenitor cell has been generated by the method of any one of claims 19 or 20.

20. A method for culturing a progenitor cell, said method comprising incubating the progenitor cell in tissue culture medium comprising a phosphate mimic.

21. The method of claim 20, wherein the tissue culture medium comprises a phosphate mimic, and wherein the culture medium is not supplemented with exogenously added growth factor.

22. The method of claim 20, wherein the tissue culture medium comprises a phosphate mimic, and wherein the incubating step increases intracellular ATP levels in the progenitor cell by at least 25% compared to intracellular ATP levels in the progenitor cell incubated without phosphate mimic under otherwise same conditions.

45. The method of claim 20, wherein the progenitor cell undergoes self-renewal.

23-28. -28. (canceled)

36. (canceled)

38-43. -43. (canceled)